Ceftriaxone-associated acute gallbladder enlargement - an unexpected diagnosis in the child with urinary tract

Grażyna Krzemień1, Tomasz Książczyk2, Agnieszka Szmigielska1

  • 1Department of Pediatrics and Nephrology, The Medical University of Warsaw, Poland.

Insights

Ceftriaxone treatment can cause biliary sludge and pseudolithiasis, a usually asymptomatic complication. Monitoring is recommended for patients on this antibiotic to detect these gallbladder changes.

Area of Science:

  • Pediatric infectious diseases
  • Gastroenterology
  • Pharmacology

Background:

  • Ceftriaxone is a widely used antibiotic for various infections.
  • Biliary sludge and pseudolithiasis are known potential side effects of ceftriaxone treatment.
  • These complications typically occur in 3-57% of patients and are often asymptomatic.

Observation:

  • A case study involving a 5-month-old boy treated for acute pyelonephritis is presented.
  • Routine ultrasound revealed gallbladder enlargement on the 5th day of ceftriaxone therapy.
  • Subsequent ultrasounds showed the development of biliary sludge, with no clinical symptoms observed.

Findings:

  • The patient exhibited gallbladder enlargement and biliary sludge during ceftriaxone treatment.
  • These findings are consistent with known ceftriaxone-induced biliary complications.
  • The gallbladder abnormalities resolved completely six weeks after discontinuing the antibiotic.

Implications:

  • Healthcare providers should be aware of the potential for ceftriaxone-induced biliary sludge and pseudolithiasis.
  • Monitoring patients on ceftriaxone, particularly with prolonged use or in pediatric populations, may be warranted.
  • Early detection and discontinuation of the drug can lead to resolution of these biliary complications.
Abstract

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
660
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
1.2K
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
402
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
46
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
1.2K
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
1.1K